One Quick Test.
No More Trial and Error in Prescribing.
A turnkey Pharmacogenomic (PGx) testing program built for healthcare organizations. No lab build, no validation cost and no new staff. Global Clinical Services runs it end to end.
Lab Partner
Why PGx Testing Matters
in Patient Care
A patient's genetic profile does not change. Their medication list does.
Patients are often on many medications and start new ones fast. PGx results give prescribers and pharmacists drug-gene insight at the point of care and stay useful for the rest of the patient’s life.
✓ Flag drug-gene interactions before the first dose
✓ Reduce adverse drug events and trial-and-error prescribing
✓ Support fewer readmissions and ED returns
The value for your organization
A Send-Out Test
No Validation Costs
A send-out test through a CLIA high-complexity partner lab. No equipment, validation or added lab cost.
No New Staff
Our team handles enrollment, benefits verification, clinical review and results delivery, so there is no headcount to add.
No Lengthy Delays for Z-Codes
Our lab's tests already have assigned Z-Codes, so you skip the long wait to register a new test before billing.
Who to test
Who Benefits Most from PGx Testing
Flag candidates in your EMR using simple criteria across the service lines where drug-gene interactions matter most.
Polypharmacy
Patients on five or more medications
Cardiology
Clopidogrel, warfarin and statin therapy
Pain Management
Opioids such as codeine and tramadol, plus NSAIDs
Behavioral Health
Antidepressants and antipsychotics
Neurology
Antiseizure medications such as phenytoin
Oncology
Hormone therapy such as tamoxifen
A turnkey program
Everything Your Team Needs, Ready on Day One
Our program is modeled on a PGx service already running in daily hospital workflow. You get the program, the tools, the process and the training.
The Program
Send-out PGx testing through AchieveDx, a CLIA high-complexity lab
The Tools
Recommended EMR criteria, requisitions and patient education materials
The Process
An eight-step workflow our team manages end to end
The Training
Role-based PGx training for clinicians and pharmacists
End-to-end program support
From Patient Identification to Results for the Care Team
Patient Identification
Eligible patients identified by service line and medication profile.
Physician’s Written Order
The treating physician orders the PGx test.
Patient Consent
Patient education and informed consent collection.
Sample Collection
A simple cheek swab collected on site.
Ship to Lab
Samples ship to our CLIA high-complexity partner lab.
Results Deposited in EMR
Completed results are placed in the patient’s electronic medical record.
Pharmacist Interprets Results
A pharmacist reviews results and flags clinically relevant drug-gene interactions.
Physician Reviews Results
The physician reviews the interpretation and adjusts therapy as needed.
Proven in practice
Built on a Program Already in Daily Hospital Use
PGx testing is already part of daily clinical workflows in a hospital program. This experience provides a practical model for integrating testing into routine care across other healthcare settings.
PGx embedded in daily workflow
The hospital workflow offers a model that could be adapted for other clinical settings.
Advancing PGx Testing
Through Strategic Partnerships
Global Clinical Services is committed to helping expand access to Pharmacogenomic (PGx) testing through collaboration, education and industry engagement.
Proud to partner with healthcare associations, health systems and provider groups to bring PGx testing into routine care.
Pharmacogenomic (PGx) Gene–Drug Lookup
Search for a medication by name, or use the filters below to browse by gene, predicted phenotype, or therapeutic category.
Results
Outcome guidance in this tool is based on published clinical pharmacogenomics guidelines (CPIC, FDA drug labeling, and DPWG) and general pharmacology where a guideline doesn't yet exist for a specific medication. Hover the Guideline-sourced or Extrapolated badge on any row for its specific source.
Please note this chart and the content contained in the chart is for informational purposes only. The content is not intended as a substitute for obtaining medical advice, a professional diagnosis or treatment from a healthcare professional. Please do not take any healthcare action, or rely on any information provided, based on the content of the chart, without first talking to your healthcare professional. Do not disregard medical advice, delay seeking medical care or discontinue treatment or medication based on any content in the chart.
Reference panel — 8 genes, 93 gene–drug pairs, sourced from the AchieveDx GenewiseRx requisition formCurious About the Process?
See how Global Clinical Services runs the PGx program from patient identification through clinical review and results delivery.